Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

2 recruiting2 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03767595Not ApplicableRecruiting

ProACT Post-Approval Study

Role: lead

NCT04248283Not ApplicableRecruiting

Adjustable Continence Therapy (ACT) for the Treatment of Female SUI

Role: lead

NCT00113555Not ApplicableCompleted

Adjustable Continence Therapy (ACT) Device for the Treatment of Female Stress Urinary Incontinence

Role: lead

NCT00277095Not ApplicableCompleted

ProACT Therapy for the Treatment of Stress Urinary Incontinence in Males

Role: lead

All 4 trials loaded